US Patent Issued on Nov. 25 for "Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligand" (Massachusetts Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,904, issued on Nov. 25.

"Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligand" was invented by Gray D Shaw (Plymouth, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of using soluble tandem selectin glycoprotein ligand (TSGL) and TSGL fusion proteins, such as TSGL-Ig, for therapeutic treatment of cancers, including in combination with T cell activation therapies or an adoptive cell transfer (ACT) therapy."

The patent was filed on Dec. 20, 2018, under Application No. 16/957,169.

*For further information, including images, charts and tables, please visit: http...